Tommy Tuberville
Tommy Tuberville (Senate) has 12 publicly disclosed stock trades on record, tracked and backtested by CapitolRadar. Updated daily from official disclosure data.
Backtested track record
Tommy Tuberville is active in the record from 2024-03-08 to 2025-12-17; 46 distinct tickers; estimated disclosed buy volume of about $261,006 (midpoints of the reported ranges).
Committee assignments: Senate Committee on Agriculture, Nutrition, and Forestry; Senate Committee on Agriculture, Nutrition, and Forestry — Commodities, Derivatives, Risk Management, and Trade; Senate Committee on Agriculture, Nutrition, and Forestry — Food and Nutrition, Specialty Crops, Organics, and Research; Senate Committee on Agriculture, Nutrition, and Forestry — Rural Development, Energy, and Credit; Senate Committee on Armed Services; Senate Committee on Armed Services — Personnel. Committee work is public; CapitolRadar lists it so readers can judge for themselves whether a trade sits close to a member's legislative remit.
Methodology: every disclosed buy is scored on its forward return versus the S&P 500 (SPY) over the next 30 and 90 days. A grade needs at least 5 scored buys.
CapitolRadar analysis
66 trades, with sells accounting for 54
Tommy Tuberville disclosed 66 trades across 46 tickers from March 8, 2024, through December 17, 2025. The record contains 12 buys and 54 sells, so sells represented most of the reported activity. Estimated disclosed buy volume was about $261,006, calculated from the midpoints of reported transaction ranges. That total is an estimate rather than an exact amount because congressional disclosures report value ranges.
The buy side was spread broadly. HUMA and ARKK were the most frequently bought securities, with two purchases each. XLU, XLP, RYCEY, XBI, ABNDX and WBA each appeared once among the listed buys. Even the leading names therefore reflect only two transactions apiece, a small sample that does not establish a sustained trading pattern.
2024 Q2 contained five of the 12 buys
Quarterly activity was highest in 2025 Q2, with 14 trades, although none were buys. The record shows 10 trades and two buys in 2025 Q4; five trades and no buys in 2025 Q1; nine trades and no buys in 2024 Q4; six trades and one buy in 2024 Q3; 11 trades and five buys in 2024 Q2; and 11 trades and four buys in 2024 Q1. The quarterly figures show that nine of the 12 disclosed buys occurred in the first two quarters covered.
No performance grade from zero scored buys
The backtest is not yet graded because zero buys have been scored, while a grade requires five. With no scored observations, the disclosures do not support a performance conclusion. The record should also be read with timing and reporting limits in mind: disclosures can carry a 45-day lag, and transaction amounts are reported as ranges rather than exact values.
Tuberville serves on the Senate Committees on Agriculture, Nutrition, and Forestry and Armed Services, including listed subcommittees covering commodities and trade, food and nutrition, rural development and energy, and personnel. Committee assignments provide context, but the disclosed data alone do not establish a connection between those roles and any trade.
Analysis written from the tracked record on 2026-08-23; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2025 Q4 | 10 | 2 | 8 |
| 2025 Q2 | 14 | 0 | 14 |
| 2025 Q1 | 5 | 0 | 5 |
| 2024 Q4 | 9 | 0 | 9 |
| 2024 Q3 | 6 | 1 | 5 |
| 2024 Q2 | 11 | 5 | 6 |
| 2024 Q1 | 11 | 4 | 7 |
Latest disclosed trades
| Date | Ticker | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2025-12-17 | XLU | buy | $15,001 - $50,000 | — |
| 2025-12-17 | XLP | buy | $15,001 - $50,000 | — |
| 2025-12-17 | GOOGL | sell | $1,001 - $15,000 | — |
| 2025-12-17 | AAPL | sell | $50,001 - $100,000 | — |
| 2025-10-07 | GOOGL | sell | $15,001 - $50,000 | — |
| 2025-10-07 | AAPL | sell | $15,001 - $50,000 | — |
| 2025-10-07 | OC | sell | $15,001 - $50,000 | — |
| 2025-10-07 | ORCL | sell | $15,001 - $50,000 | — |
| 2025-10-07 | MSFT | sell | $15,001 - $50,000 | — |
| 2025-10-07 | PEP | sell | $15,001 - $50,000 | — |
| 2025-04-15 | GS | sell | $15,001 - $50,000 | — |
| 2025-04-15 | ADM | sell | $15,001 - $50,000 | — |
| 2025-04-15 | AMGN | sell | $15,001 - $50,000 | — |
| 2025-04-15 | QCOM | sell | $15,001 - $50,000 | — |
| 2025-04-15 | AAPL | sell | $15,001 - $50,000 | — |
| 2025-04-15 | STZ | sell | $15,001 - $50,000 | — |
| 2025-04-15 | DUK | sell | $15,001 - $50,000 | — |
| 2025-04-15 | LLY | sell | $15,001 - $50,000 | — |
| 2025-04-15 | BMY | sell | $1,001 - $15,000 | — |
| 2025-04-15 | PYPL | sell | $15,001 - $50,000 | — |
Most-bought stocks
HUMA (2) · ARKK (2) · XLU (1) · XLP (1) · RYCEY (1) · XBI (1) · ABNDX (1) · WBA (1)
Frequently asked questions
What stocks did Tommy Tuberville buy recently?
Most recently disclosed buys: XLU (2025-12-17), XLP (2025-12-17). STOCK Act filings can arrive up to 45 days after the trade, so the newest weeks fill in late.
What is Tommy Tuberville's most traded stock?
HUMA, with 2 disclosed buys on record, followed by ARKK.
Does Tommy Tuberville beat the market?
Not enough scored buys yet to say: a CapitolRadar grade needs at least 5 buys with 30 days of market history after them. The grade appears automatically once the record matures.
How often does Tommy Tuberville trade?
About 9.4 disclosed trades per quarter across the last 7 quarters on record, with the busiest quarter at 14 trades.
Where does this data come from?
From official public filings — congressional STOCK Act periodic transaction reports — ingested and backtested daily by CapitolRadar. Amounts are the ranges members are required to report, not exact figures.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.